SEC Form 4 · accession 0001209191-17-046038
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M. Kaye M.D.
Director
Period of report
Jul 20, 2017
Accepted (ET)
Jul 21, 2017 · 9:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 20, 2017 | F | 4,349 | $40.93 | D | 62,471 | D | |
| Common StockF2 | Jul 20, 2017 | S | 10,000 | $41.00 | D | 52,471 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.
- F2This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.